TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05787574: A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

Sponsor: Joseph Oved · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 39 pts

Competing Trials Overlap

9 Active Trials

Excess Burn Exposure

$1,690,500

Rescue Site Savings

+$1,104,000

Unlock Full NCT05787574 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05787574 Rescue Dossier →